SULLIVAN TIMOTHY EUGENE (Chief Financial Officer) reported 2 transactions at APELLIS PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 4/20/2026ACC: 0001193125-26-163917
Officer· Chief Financial Officer
Since Feb 2019
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
11.10K acquired · 11.10K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−11.10K
Price / share
—
Trade value
—
% of position
7.3%
4/17/2026
152.04K→140.94K
Common Stock
Indirect
Shares
+11.10K
Price / share
—
Trade value
—
% of position
18.4%
4/17/2026
60.40K→71.49K
Total
Net shares
+0.00
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/17/2026 | G · Gift | −11.10K | — | — | 7.3% | 152.04K | 140.94K |
| Common Stock Indirect | 4/17/2026 | G · Gift | +11.10K | — | — | 18.4% | 60.40K | 71.49K |
| Total | +0.00 | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported